FGFR Inhibitor ET0111 Monotherapy in Patients With Advanced Solid Tumors

Clinical trial NCT05522309 · UNKNOWN

Trial details

NCT number: NCT05522309
Sponsor: Etern BioPharma (Shanghai) Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-08-30
Primary completion: 2024-12-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.